0001209191-19-048804.txt : 20190906
0001209191-19-048804.hdr.sgml : 20190906
20190906174638
ACCESSION NUMBER: 0001209191-19-048804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190905
FILED AS OF DATE: 20190906
DATE AS OF CHANGE: 20190906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cory David A
CENTRAL INDEX KEY: 0001670137
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 191080482
MAIL ADDRESS:
STREET 1: 350 CAMBRIDGE AVENUE, SUITE 350
CITY: PALO ALTO
STATE: CA
ZIP: 94306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-05
0
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001670137
Cory David A
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
1
1
0
0
President and CEO
Common Stock
2019-09-05
5
A
0
E
1500
7.9475
A
67846
D
Common Stock
29780
I
See footnote
These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Represents the Reporting Person's proportionate interest in securities held by Eiccose, LLC ("Eiccose"). The Reporting Person is a managing member and significant equity interest holder of Eiccose. The Reporting Person hereby disclaims any beneficial ownership of any shares directly held by Eiccose, except to the extent of its pecuniary interest therein.
/s/ Sriram Ryali, Attorney-in-Fact
2019-09-06